title: Suspected adverse events, 2012.
abstract: Increase in serious adverse events; Increase in reports involving products marketed under the Small Animal Exemption Scheme; Decrease in injection site reactions. These are some of the results from the surveillance work carried out by the pharmacovigilance unit at the Veterinary Medicines Directorate (VMD), as discussed by Giles Davis and colleagues.
authors: Suspected Adverse Reaction Surveillance Scheme, Veterinary Medicines Directorate, Woodham Lane, New Haw, Surrey KT15 3LS.
authors: G
authors: G
authors: Davis
authors: A
authors: A
authors: Rooney
authors: S
authors: S
authors: Cooles
authors: G
authors: G
authors: Evans
mesh_terms: D000818:Animals; D006801:Humans; D011358:Product Surveillance, Postmarketing; D006113:United Kingdom; D019155:Veterinary Drugs / Q000009:adverse effects*; D014730:Veterinary Medicine
chemical_list: D019155:Veterinary Drugs